Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.
about
Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 proteinRegulation of STATs by polycystin-1 and their role in polycystic kidney diseaseExperimental therapies and ongoing clinical trials to slow down progression of ADPKDSystems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney diseasePyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathwaysThe Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.c-Met and NF-κB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease.STAT3 Signaling in Polycystic Kidney DiseaseThe regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions.Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside.Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer MicroenvironmentRheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosisPeriostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease.Abnormal glycosylation in Joubert syndrome type 10.Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications.Immune mediators in the brain and peripheral tissues in autism spectrum disorder.Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling.USP8 modulates ubiquitination of LRIG1 for Met degradation.Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody.Primary Cilia in Cystic Kidney Disease.Insights into autosomal dominant polycystic kidney disease by quantitative mass spectrometry-based proteomics.Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.Signaling through the Primary Cilium.The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.Mammalian target of rapamycin complex 1 activation in podocytes promotes cellular crescent formation.A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease
P2860
Q24299323-961F07A7-B297-43EB-BE7C-9F69930A8084Q24299480-F0EBC2FD-FBA8-45FC-BABF-3BCE16227E5AQ26852136-DEDCA687-B0CA-4FD9-8EFC-5B4C5D91A66EQ27001230-2DA4DBED-CABF-46B9-932C-70C4B43AC961Q28587166-7034DEAC-03BF-480C-BB7C-F2D7CA581DD6Q33984585-9C4D5AB4-2C3C-4ECC-8A91-DDB3126CECE8Q36003176-8181B784-8CC0-4E69-AF81-930363C5DF5EQ36109160-939688BD-2DF6-4DCE-AD1F-6231741D6805Q36218762-8991DCDB-511C-46AD-9B5F-C24EC1531BFAQ36254097-3414C273-5119-48D5-B286-384EFA21C27FQ36471777-76DF7704-D99D-48F1-B396-0187A491CC0DQ36759077-60B081CA-1D64-4556-B52E-8A996CC91E5AQ36977335-C98B88AF-CA3B-4DAA-ADD5-DFB3CFC2C893Q37678557-B0BE90D3-27ED-4D90-9F8C-5785DC1A28CCQ37719527-FEF754D0-C9B1-49BF-ACB7-70BAFCA7A6FEQ37882447-FD71F0B2-7580-4A61-8BCA-15A9EFE3FB7DQ38002007-244B3A8E-AF22-4327-A1DC-2F0AAD323A1BQ38550206-37E8EBEE-F9EC-4AB2-AA04-740D34A50EFCQ38957062-F1E3D5C3-52BB-4CF1-B385-2D76B59B966AQ38994990-B716F6B9-421A-420A-8079-E8D9B557B343Q39233148-1A334ACF-E097-4F3F-B015-B5EF6DDEFD03Q39242476-F5B21DC8-2281-4ADE-B2BA-C07A0B2475F4Q39255681-B3470B03-AE9F-443A-85F5-F844289B92EAQ41667238-FC346717-BAD8-4653-A350-65FEBC8F8DB0Q50280734-A174F254-FE07-4CC5-BED3-7C808AC03B0AQ50944400-9A76FE4B-8EF5-40C9-BC4F-F6D0BA14434FQ54340348-A3AB3D2C-3210-486C-81CD-79326433E526Q57652249-64F91A65-798C-4027-8C74-74072A115884
P2860
Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@ast
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@en
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@nl
type
label
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@ast
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@en
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@nl
prefLabel
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@ast
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@en
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@nl
P2093
P2860
P356
P1476
Failure to ubiquitinate c-Met ...... ant polycystic kidney disease.
@en
P2093
Ayumi Takakura
Jordan A Kreidberg
Leah Contrino
Mary Taglienti
Surya M Nauli
P2860
P304
P356
10.1172/JCI41531
P407
P577
2010-09-13T00:00:00Z